Physician Wealth Advisors’s Akero Therapeutics AKRO Stock Holding History

Physician Wealth Advisors’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-36	Closed	-$1.71K	–	2039
2025 Q3	$1.71K	Sell	36 -8	-18%	-$387	﹤0.01%	1300
2025 Q2	$2.35K	Buy	+44	New	+$2K	﹤0.01%	992

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Physician Wealth Advisors's AKRO Position: Q4 2025 in Review

Physician Wealth Advisors sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 36 shares — an estimated $1.71K sold.

Physician Wealth Advisors first reported a position in AKRO in Q2 2025 and held it in 2 quarters. The position peaked at $2.35K in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Physician Wealth Advisors reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Physician Wealth Advisors sold 36 Akero Therapeutics shares in Q4 2025, an estimated $1.71K.
Physician Wealth Advisors first reported a position in Akero Therapeutics in Q2 2025 and held it in 2 quarters.
Physician Wealth Advisors's Akero Therapeutics position peaked at $2.35K in Q2 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Physician Wealth Advisors's 13F filing for Q4 2025, filed 29 Jan 2026.